Stem Cell Blog
Употребата на матичните клетки од папочна врвца рапидно се зголемува. Пред 10 години крвта од папочна врвца можеше да лекува околу 40 состојби, но денес таа бројка е над 80. Со нетрпение очекуваме нови терапии за болести и нарушувања како што се дијабет, аутизам и мозочен удар, можете да бидете во тек со најновите случувања во регенеративната медицина на нашиот блог за матични клетки.
This year’s World Sickle Cell Day is on the 19th June, a day to recognise and raise awareness of the disease, the millions around the world who suffer from it, and ongoing research into how treatment is advancing.
With this year’s theme being ‘we are STRONGER TOGETHER’, we thought it would be a good opportunity to highlight how cord blood transplants between siblings have emerged as a viable treatment alternative for those suffering from the condition.
Making use of sibling cord blood necessitates having it in storage and so in celebration of World Sickle Cell day, we wanted to highlight how cord blood banking could provide a lifeline for those suffering from the disease, as well as how storing cord blood for your baby could help safeguard the health of your family.
What is sickle cell disease?
Sickle cell disease is the name for a group of inherited blood disorders that are passed down from parents to children.
Particularly common amongst those who have African or Caribbean heritage, sickle cell disease inhibits the haemoglobin in red blood cells from carrying oxygen.
This can lead to the red blood cells in those with the condition to become misshapen, inflexible and liable to sticking together and blocking blood flow, causing tremendous pain – known as sickle cell crises – in addition to an increased risk of stroke, lung problems, eye problems and infection.
The disease gets its name from the shape of the red blood cells affected by the condition: crescent or ‘sickle’ shaped rather than discoid. [1]
What treatments are available for sickle cell disease?
Currently, treatments for sickle cell disease focus primarily on the alleviation of symptoms.
While there have been significant steps forward in recent years, including the development of the Casgevy therapy which utilises genetically engineered bone marrow stem cells from the patients themselves in lieu of a donor transplant, medicines like antibiotics and painkillers remain the most prevalent way of combating sickle cell.
There is only one known cure for sickle cell disease: a stem cell or bone marrow transplant. In these treatments, healthy red blood cells are produced by the donated stem cells, replacing the ones that are affected by sickle cell. [2]
However, difficulty in locating an unrelated donor match, in addition to the risks posed by graft-versus-host disease, hinders the ready availability of transplantation as a treatment option.
The benefits of cord blood banking for sickle cell disease
Within the last decade, sibling cord blood transplants have emerged as a viable alternative to bone marrow transplants as a treatment option for sickle cell disease.
A comprehensive study in 2017 following the success rates of sibling cord blood transplants over a period of 20 years found that of the 28 patients with sickle cell who received cord blood from a sibling, all but one are both alive and free from sickle cell disease. [3]
With a reduced risk of graft-versus-host disease, in addition to a 25% chance of a perfect match and a 50% chance of a partial match, using the stem cells from a sibling’s umbilical cord blood alleviates many of the current obstacles to obtaining a transplant to treat sickle cell disease.
Moreover, because of the way sickle cell is passed down between parents and children, if one child is born with sickle cell disease then there’s a 75% chance that a subsequent child will not have the disease, making a cord blood transplant between siblings possible. [4]
Should I store my baby’s cord blood?
Underlying the breakthroughs in treating sickle cell through a sibling cord blood transplant is one crucial detail: whether or not that sibling has cord blood samples in storage. There’s only one opportunity to save their cord blood: in the minutes after they’re born.
Without cord blood samples in storage, availability to stem cell transplant treatments for sickle cell, and other blood or inherited conditions, becomes more difficult as it’s harder to find a suitable match.
Ensuring that you save cord blood for every child maximises opportunities for treatment, particularly in instances where a sibling transplant could provide a cure for conditions requiring an HLA match, like sickle cell disease.
Additionally, with the emergence of the aforementioned Casgevy therapy and ongoing trials exploring the possibility for autologous stem cell treatments for sickle cell disease, saving your baby’s stem cells means that they have improved access to cutting edge therapies using their own cord blood samples. [5]
Storing cord blood for every child is the only way to ensure that they have improved access to the benefits of cord blood banking.
If you want to learn more about how storing cord blood for your baby could provide protection for their health and the health of their siblings, fill out the form below for a free Welcome Pack.
References
The results of a new study have found that patients who had undergone an organ transplant were able to wean themselves off anti-rejection drugs with the help of stem cells. [1]
What are anti-rejection drugs and why are they taken?
Tolerance is the holy grail of organ transplantation, the name for the body accepting the donated organ without the immune system believing it to be a foreign body and attacking it.
Currently, however, patients who undergo organ transplants are required to take immunosuppressant drugs in order to prevent what’s known as organ ‘rejection’. [2]
These drugs have to be taken for life and come with a range of unfavourable side effects, including increased exposure to infection and cancer, as well as risking damage to the donated organ.
How does the stem cell treatment work?
By transferring stem cells from the donor to the patient receiving the donated organ – in this case, a kidney – researchers in the trial hoped to induce ‘mixed chimerism’, a phenomenon whereby the organ recipient’s immune system becomes a hybrid composed of their own and their donor’s cells. [3]
Once this is achieved, the transplanted organ theoretically remains free from attack as the body no longer considers it to be ‘foreign’.
We covered a similar instance of stem cells being used to reprogramme the immune system in our blog about Aditi Shankar, who successfully underwent pioneering treatment to aid with a donated kidney last year. You can read more about Aditi’s story here.
What did the study find?
What the study found, the results of which were presented at the American Transplant Congress in Philadelphia, was that in 16 out of 19 cases, organ donor recipients who received stem cells from their HLA matched sibling no longer had to continue taking the immunosuppressant drugs after two years.
Additionally, researchers also noted improved quality of life outcomes for those who successfully underwent the treatment. [4]
What could this mean for future organ donor recipients?
Researchers in the trial are hoping that their findings can eventually result in future organ transplant recipients foregoing the need to take anti-rejection drugs. Not only are these drugs harmful but the damage they cause to the donated organ often leads to failure, resulting in a backlog of transplants. [5]
With the new treatment, any new organ transplants should theoretically be able to last a lifetime, expanding the pool of available organs in the process.
More research is needed to discover whether this treatment is viable for all types of organ transplant, beyond kidneys in this case, in addition to identifying whether the treatment is viable in cases where donated organs have been sourced through donors other than siblings.
Either way, this research is a huge step forward in the long held ambition of achieving tolerance for all organ transplant outcomes.
In this treatment researchers took advantage of the good chances of stem cell matches between siblings. The chance of a perfect stem cell match between full siblings is 1 in 4, with a 50% chance of a partial match. [6]
By saving stem cells for your baby you could not only safeguard their health, but also the health of their siblings.
If you want to know more about how saving stem cells could help protect your baby’s health, fill out your details below for a free Welcome Pack.
References
07/07/2024 BlogDiabetesNewsStem Cell News
Researchers in Shanghai have claimed to have achieved the world’s first successful cure for type 2 diabetes using stem cell-derived islet transplantation.
Publishing their findings in the journal Cell Discovery, the team of scientists believe that this new therapy offers hope for the estimated 420 million people living with type 2 diabetes around the world. [1]
What is type 2 diabetes?
Type 2 diabetes is a metabolic disorder that arises as a result of the body either being unable to produce insulin or being ineffective at using the insulin it produces in order to regulate blood sugar levels. [2]
Those with type 2 diabetes risk developing hyperglycemia, otherwise known as high blood glucose levels, as a result of being unable to metabolise glucose. Hyperglycemia can cause complications over time, including damage to organs.
Current management strategies primarily involve glycemic control through medications including insulin, as well as strict diet management to monitor blood sugar levels, leaving a substantial unmet need for a definitive cure. [3]
How did researchers develop the cure?
Scientists undertook a study centred around a 59-year-old male patient with a 25-year history of type 2 diabetes. Following a kidney transplant in 2017, the patient experienced a decline in pancreatic islet function, necessitating daily multi-dose insulin injections.
To address this challenge, the research team led by Dr. Yin Hao turned to a pioneering stem cell treatment. Utilising the patient’s own endoderm stem cells (EnSCs), they were able to differentiate these stem cells into functional pancreatic islet cells – cells in the pancreas that secrete hormones, including insulin and glucagon, that help regulate blood sugar levels. [4]
Once differentiated, these so-called ‘E-islet cells’ could then be implanted into the patient. [5]
What were the results of the transplant?
In July 2021, the patient underwent the autologous islet cell transplantation. Notably, the patient achieved insulin independence within a mere 11 weeks post-transplantation. Oral medication for diabetes management was gradually reduced and ultimately discontinued a year later.
Follow-up examinations conducted over a prolonged period revealed restored pancreatic function, with the patient no longer requiring exogenous insulin or oral medications.
Additionally, normal kidney function was maintained, suggesting a potential long-term cure for both type 2 diabetes and the underlying complications associated with the initial kidney transplant. [6]
What are the next steps in treating diabetes with stem cells?
This groundbreaking achievement signifies a paradigm shift in the treatment of type 2 diabetes.
The successful application of stem cell therapy offers a path towards a potential cure, paving the way for further research into the large-scale implementation and long-term efficacy of this novel approach.
While further clinical trials are warranted to validate these findings, this case study undoubtedly sparks hope for a future free from the burden of diabetes.
If you want to learn more about saving stem cells for your baby, download your free Welcome Pack by filling out the form below.
References
[2] Watts, M. (2023, December 14). Type 2 Diabetes. Diabetes.co.uk. https://www.diabetes.co.uk/type2-diabetes.html
[3] Chong K, Chang JK-J, Chuang L-M.Recent advances in the treatment of type 2 diabetes mellitus using new drug therapies. Kaohsiung J Med Sci. 2024;40(3):212–20. https://doi.org/10.1002/kjm2.12800220
[4] Wu, J., Li, T., Guo, M. et al. Treating a type 2 diabetic patient with impaired pancreatic islet function by personalized endoderm stem cell-derived islet tissue. Cell Discov 10, 45 (2024). https://doi.org/10.1038/s41421-024-00662-3
07/07/2024 BlogStem Cell NewsStem Cell Therapies
Fibromyalgia is a complex condition that affects millions of people worldwide, causing chronic pain, fatigue, and various other symptoms.
Despite its prevalence, the exact cause of fibromyalgia remains unknown, making it hard to treat effectively. However, recent advancements in medical research, particularly in stem cell therapy, may offer hope for those suffering from this debilitating condition.
What is fibromyalgia?
Fibromyalgia manifests as widespread musculoskeletal pain, along with fatigue, sleep problems, memory issues, and mood disorders. The condition is believed to involve problems in how the brain and spinal cord process pain signals, along with issues in neurotransmitter levels and immune function.
Unlike other rheumatic conditions, fibromyalgia does not cause inflammation or damage to joints, muscles, or tissues, which makes it harder to diagnose and treat.
How can stem cells help?
Stem cells, particularly mesenchymal stem cells (MSCs), have gained significant attention in medical research due to their remarkable regenerative and immunomodulatory properties.
MSCs are capable of differentiating into various types of cells, such as those found in bones, cartilage, and adipose tissue. Bone marrow mesenchymal stem cells have been reported as one of the most widely used cell sources for nerve regeneration. [1]
Expanded MSCs may help relieve fibromyalgia symptoms through several mechanisms. Their ability to transform into nerve and muscle cells may aid in repairing damaged tissues and restoring their function.
Additionally, their anti-inflammatory properties and ability to regulate the immune system might help address the root causes of fibromyalgia. [2]
How soon before stem cells could be used to treat fibromyalgia?
Although research on MSC therapy for fibromyalgia is still in the early stages, clinical trials are being conducted to test its safety and effectiveness in humans.
These trials aim to determine if MSC transplantation can be a viable treatment and to explore its potential to reduce symptoms and improve the quality of life for those with fibromyalgia.
While finding effective treatments for fibromyalgia is a long and challenging process, the potential of stem cell therapy offers new hope for patients and clinicians.
With continued research and innovation, we may eventually unlock the full potential of stem cells to transform the lives of those affected by fibromyalgia.
For more information about how you can save stem cells for your baby, fill out the form below for our free Welcome Pack.
References
07/07/2024 BlogStem Cell NewsStem Cell Therapies
A new study has shown that mesenchymal stem cells derived from both the umbilical cord and from fat tissues may be able to provide a therapy for ovarian ageing.
In a trial conducted using mice, researchers at the Centre for Reproductive Medicine in Beijing saw drastic improvements in ovarian function after administering stem cells, improvements that may be an important step in eradicating the ‘biological clock’.
What is Ovarian Ageing?
Ovarian ageing is a natural process whereby the quality and quantity of both oocyte (eggs) and ovarian follicles (small fluid filled sacs that contain eggs) diminishes over time.
While it is inevitable that the human body should age, the ovaries age faster than many other organs, with characteristics of senescence emerging around 30-35 years of age. [1]
This rapid ageing process can be both troubling and distressing, leading to age-related infertility, a severe obstacle to many women who want to have children later in life.
Indeed, recent trends indicate that as a result of a myriad of socio-economic factors, motherhood is becoming more and more delayed, meaning an increasing number of women are being diagnosed with female infertility and being forced to utilise assisted reproductive technologies in order to have a child. [2]
How could stem cells help with ovarian ageing?
Because mesenchymal stem cells are able to differentiate into other specialised cell types in the body, it’s thought that they may be able to repair the damage ovaries incur through the ageing process and reinstate the cellular environment required for follicular renewal. [3]
What did the study find?
In the aforementioned study, scientists took umbilical cord and adipose tissue derived mesenchymal stem cells and injected them into the ovaries of mice with reduced reproductive functions.
A break from previous studies that injected stem cells into the tails of mice, this trial utilised a process known as orthotopic transplantation, which delivered the stem cells closer to the ovaries.
They then monitored the results of the application over an eight day period to determine the impact on the mice’s oestrous cycle – a phenomenon that has similarities to the hormonal changes during the menstrual cycle in human females.
What they found was that in the mice who had undergone umbilical cord derived stem cell transplantation there were drastic improvements to the duration of this cycle.
Between weeks 1 and 3 the mice were then sacrificed in order to analyse the changes to their tissues.
Analysis of the ovaries of the older mice revealed that the MSCs dramatically increased the proportion of proliferating cells.
Additionally, the number of primary follicles and blood vessel proliferation also increased as a result of the injection, along with a notable uptick in the expression of signalling pathways relevant to the regulation of inflammation in the ovaries. [4]
There were no significant toxic reactions to the treatment, nor were the MSCs determined to be tumorigenic (meaning no risk of the cell transplantation resulting in the proliferation of malignant tumours).
While there is still a long way to go before this potential treatment reaches clinical trial in humans, initial results from this study, and others like it, are highly promising for treating ovarian ageing.
If you want to find out more about how to save umbilical cord stem cells for your baby, download our free welcome pack below.
References
In a study first published in April’s edition of Advanced Functional Materials, researchers found that stem cells boost natural repair following cardiac arrest.
The most common consequence of cardiac arrest is brain injury. Decreased blood flow and oxygen to the brain can result in damage to specific areas such as the temporal lobe, which is responsible for memories. [1]
According to the British Heart Foundation, there are around 30,000 out of hospital cardiac arrests in the UK per year, with survival rates of only 1 in 10.
While there are currently steps towards improving these survival rates – mainly public awareness and educational campaigns focused on immediate response [2] – better survival rates potentially means more patients suffering from brain injury, which can range in severity.
What researchers at the University of Maryland School of Medicine in the U.S. have found is that neural stem cells can help with repairing post-cardiac arrest brain damage when their carbohydrate structure is manipulated. [3]
In an animal study using rats, scientists applied sugar molecules to the neural stem cells in a process called glycoengineering.
It’s thought that the application of these sugar molecules provide the neural stem cells with a better chance of retention and integration within the harsh microenvironment of the brain.
Researchers examined the efficacy of the ‘sugar-coated’ neural stem cells that had been pretreated with TProp (the name of the modified sugar molecule applied) with naive human neural stem cells.
They found through subsequent testing that the stem cells that had been pretreated with TProp improved brain function substantially, along with reducing anxiety and depression-related behaviours.
The ability for synapses to modify the strength of their connections (otherwise known as synapse plasticity) also improved, with the TProp group also demonstrating a reduction in neuroinflammation in the central nervous system.
Overall, the findings from the University of Maryland are promising as they indicate that these glycoengineered stem cells could help regenerate connections between synapses in the brain that have been affected by cardiac arrest related injury in humans.
The next steps will involve tests on larger animals before hopefully moving to a clinical study.
If you want to know more about how you can save your baby’s powerful stem cells, fill out the form below for your free welcome pack.
References
Researchers at Vienna University of Technology have taken an important step in making lab-grown cartilage a possibility by utilising a new technique involving 3D printing and stem cells. [1]
The process involves a high-resolution 3D printing process to create small, football-shaped spheres that act like porous scaffolds within which differentiated cartilage stem cells can sit.
These spheroid scaffolds can then be molded into various shapes in order to fit like puzzle pieces into seamless tissue structures.
One of the main challenges in attempting to form artificial cartilage using stem cells thus far has been the inability for scientists to leverage much control over the shape of the resulting tissue.
The key advantage of the 3D printed spheroid, cage-like structures, which are around a third of a millimetre in diameter, is that they’ve enabled the researchers in Austria to form combinable, compact building blocks from which to grow cartilage tissue.
Importantly, the team at TU Wien also showed that when combined, neighbouring spheroids actually grow together, with the cells from one spheroid migrating to another, connecting in a closed, continuous structure. [2]
The 3D printed plastic scaffolds provide mechanical stability to the tissue as it continues to grow, up until the point at which they are no longer needed. The spheroids then degrade, leaving behind cartilage tissue shaped in the way desired.
A huge breakthrough for facilitating the regenerative potential promised by stem cells – particularly mesenchymal stem cells, which have the ability to differentiate into a range of specialised cells [3] – this new technique could be used in growing other tissues beyond cartilage into shapes required for repair at the cellular level.
For the time being, however, the researchers’ next aim is to attempt to use their 3D printed spheroids in the formation of tailormade pieces of cartilage tissue that can then be inserted into damaged areas of the body following injury.
If you’re interested in learning more about how saving stem cells for your baby could give them access to future regenerative treatments, download our free welcome pack below.
References
A recent study published in the journal eBioMedicine found that umbilical cord stem cells may have the potential to heal the intestinal ulcers of patients suffering from Crohn’s disease.
What is Crohn’s disease?
Crohn’s disease is a condition that causes parts of the digestive system to become inflamed. The disease affects around 1 in every 300 people in the UK, with symptoms including severe abdominal pain, diarrhoea, tiredness and fatigue, appetite loss and in some cases, anaemia. [1] [2]
A lifelong condition, the root causes of Crohn’s aren’t yet known, but it’s thought that there are several key factors that may contribute to the likelihood of developing the disease, such as:
-
Having had a particularly pernicious stomach bug
-
Whether any close relatives have Crohn’s (genes)
-
If there’s a preexisting immunological problem
-
If there’s an imbalance in gut bacteria levels
-
Exposure to a range of environmental factors, including stress, smoking, taking certain medicines such as antibiotics and non-steroidal anti-Inflammatory drugs (NSAIDs).
Unfortunately, there are no cures available for Crohn’s disease, with treatments limited to reducing the inflammation and severity of symptoms through medicinal, although this only has an efficacy rate of 40-60%, or surgical means which involves removing a portion of the digestive system. [3]
With this in mind, the need to find a new approach to the treatment of Crohn’s has a pressing urgency.
Exploring the application of umbilical cord stem cells for treating Crohn’s disease
Researchers conducted a pilot, open label clinical study between November 2020 to October 2023, with 17 patients with Crohn’s disease.
The patients, who were aged between 18 to 75, were selected on the basis that they had moderate to severe Crohn’s disease for at least three months prior to the start of the trial and that they had not responded to advanced treatment.
Patients received an injection of human umbilical cord mesenchymal stem cells (hUC-MSCs) both by colonoscopy and then by intravenous drip the following day. Patients were then monitored over the course of 24 weeks, with researchers measuring laboratory and clinical markers along with performing endoscopic assessments.
The researchers found that of the 17 patients, eight showed improvement in their SES-CD (Simple Endoscopic Score for Crohn’s disease) scores, which measures the size and severity of ulcers wherein a higher score indicates a more severe disease, while 3 further patients also displayed mucosal healing, meaning their SES-CD scores became zero.
All patients achieved clinical remission by week 24 of the trial. [4]
How does the treatment work?
During the course of the trial, the researchers were paying special attention to how the mesenchymal stem cells were working to provide such dramatic improvements in patient outcomes. In addition to showing the viability of the stem cell treatment, they also wanted to show how that treatment worked.
They did this by taking a biopsy of the mucosae at the margins of the intestinal lesions from 3 patients before and after the trial for transcriptome sequencing, a process that would allow them to access information about the gene regulation and protein content of cells.
The researchers’ analysis revealed that the hUC-MSCs appeared to upregulate the expression of genes that maintain the integrity of the intestinal epithelial barrier – a mucus layer that regulates luminal contents (such as enzymes, food particles, bile and bacteria) and its interaction with the body’s immune system – and downregulated the expression of genes relating to inflammatory response. [5]
Essentially, what this suggests is that the application of stem cells led to the inhibition of the inflammatory response and an improvement in the integrity of the intestinal barrier, remedying two key aspects of intestinal function affected by Crohn’s disease.
While there were limitations in the size and scope of this trial, what it showed was significant and promising potential for the effective application of umbilical cord stem cells in treating Crohn’s disease, a huge step forward in making available a new avenue of treatment for those who live with the condition.
If you want to find out more about how you could give your baby access to their own umbilical cord and placental stem cells, sign up below for a free welcome pack.
References
02/05/2024 BlogStem Cell TherapiesUses for Placenta
The formation of the placenta represents a pivotal moment in pregnancy. Often thought of as the life support system for the growing foetus, the placenta represents the beginning of the nurturing bond between mother and child.
An intricate organ, the placenta undergoes a process of development that is at once fast and yet also remarkable, and is essential to the growth and health of your new baby.
In this blog, we’ll answer some of the most important questions about the placenta, like ‘what is the placenta?’, ‘when does the placenta form?’, and ‘what does the placenta do?’. We’ll also cover how the placenta could hold the key for unlocking the future of medicine.
What is the placenta?
The placenta is a temporary organ that is a bit like a pancake in shape and comes to measure around 20 cm in diameter and is on average 3 cm thick at the point of delivery. [1] It forms in the womb, also known as the uterus, during the first few weeks of pregnancy and attaches to the uterine wall where it is connected to your baby via the umbilical cord.
When does the placenta form?
The formation of the placenta usually begins at around week four of pregnancy.
Approximately a week after a sperm fertilises an egg about 120 cells called the blastocyst implant themselves into the wall of the womb. Around two thirds of these cells split away and implant themselves deeper into the uterine wall where, instead of preparing to develop into the arms, legs and other body parts of your baby, they will prepare to form into the placenta. [2]
From there the placenta will continue to develop over the next two months, taking over the role of the corpus luteum – a collection of cells that produce progesterone, a hormone necessary for sustaining the foetus during the early stages of pregnancy – at around weeks 10-12. [3]
The placenta will then be solely responsible for sustaining your baby into the second and third trimesters.
What does the placenta do?
The placenta has a myriad range of functions that help to sustain and protect your baby while it grows in the womb. [4]
These include:
- Providing your baby with oxygen while also removing carbon dioxide.
- Transferring vital nutrients such as water, amino acids, vitamins and glucose from mum to baby.
- Carrying away waste substances from the baby, like urea, uric acid and bilirubin (a substance made during the breakdown of red blood cells).
- Ensuring that the transfer of nutrients and waste occurs without mixing the blood of the baby with that of the mum’s.
- Passing antibodies to the baby close to delivery which provide it with immunity both in the womb and during the first few months of its life, effectively kickstarting its immune response.
- As well as being an organ, the placenta is also an endocrine gland, meaning it produces powerful hormones and signalling molecules such as lactogen, progesterone, oestrogen, oxytocin and relaxin which are vital for both mum and baby during pregnancy.
What can I do with my placenta after my baby is born?
Even after baby is born, the placenta still has a range of uses and applications.
Placentophagy
Among the most popular of these are forms of placentophagy, otherwise known as the consumption of the placenta. This can be done in a few ways, either through steaming or cooking, but it can also be dehydrated and encapsulated into pills that mothers can take in the first few weeks after birth.
So far, the benefits of placentophagy are only supported by anecdotal evidence, most of which points to potential improvements in energy levels, milk supply, and mood along with reductions in the likelihood of insomnia, bleeding and postpartum pain. However, it’s worth noting that there are safety concerns around the susceptibility of the placenta to infection.
If you’re planning on eating your placenta then it’s worth discussing the process with your GP or dedicated health professional, along with alerting your hospital that it’s something you want to include in your birth plan. [5]
Placenta banking
It’s been widely noted that the placenta and amnion are both rich sources of various kinds of stem cells. These are cells that have the ability to differentiate into a range of specialised cells throughout the body, and are currently undergoing research in numerous clinical trials for the application in treating a wide range of degenerative diseases. [6] [7]
Here at Cells4Life, we offer expectant parents the chance to store these powerful cells from both the amniotic membrane and chorionic villi of the placenta so that they’re in reserve should your baby ever need them in a future regenerative therapy.
If you’re interested in learning more about storing stem cells for your baby, fill out the form below to download our free welcome pack, which contains comprehensive information about our safe and simple services. It could be something that makes all the difference.
References
Cells4Life Group LLP,
Units 2-3 Oak House, Woodlands Office Park,
Albert Drive, Burgess Hill, RH15 9TN, UK.
Med Bio Genetics
Pero Nakov 110, Skopje, Republic Macedonia
+389 70 221 602
info@cells4life.mk
